KIT | KIT-Bibliothek | Impressum | Datenschutz

The effects of regulative instruments on stakeholders in the German pharmaceutical market

Haustein, Robert

Abstract:
The German Statutory Health Insurance (SHI) system provides medical services for the majority of the German population. Prescription drugs are a large cost driver of the system. Regulative instruments were introduced to reduce the drug expenditures. The aim of this thesis is to evaluate the effects of the implementation of reference pricing, co-payment exemption and rebate contracts on key parties of the SHI prescription drug market between 2004 and 2007.

Open Access Logo


Volltext §
DOI: 10.5445/IR/1000034990
Cover der Publikation
Zugehörige Institution(en) am KIT Institut für Volkswirtschaftslehre (ECON)
Publikationstyp Hochschulschrift
Publikationsjahr 2013
Sprache Englisch
Identifikator urn:nbn:de:swb:90-349900
KITopen-ID: 1000034990
Verlag Karlsruher Institut für Technologie (KIT)
Art der Arbeit Dissertation
Fakultät Fakultät für Wirtschaftswissenschaften (WIWI)
Institut Institut für Volkswirtschaftslehre (ECON)
Prüfungsdaten 14.05.2013
Referent/Betreuer Prof. K. Mitusch
Schlagwörter Regulative Instruments, Reference Pricing, Rebate Contracts
KIT – Die Forschungsuniversität in der Helmholtz-Gemeinschaft
KITopen Landing Page